Twist Bioscience Corporation TWST Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$44.02M-44.3% | -$30.51M-12.4% | -$27.14M-233% | $20.39M+152% | -$39.33M-24.5% | ||
| $6.41M+3.6% | $6.19M+3.2% | $6M-1.0% | $6.07M-5.3% | $6.4M+0.4% | ||
| $18.94M+42.7% | $13.27M-17.5% | $16.08M+0.2% | $16.06M-21.0% | $20.33M+69.5% | ||
| $14.24M+309% | -$6.83M-195% | $7.21M— | $0-100% | $10.72M+136% | ||
| $590K-87.2% | $4.62M+94.9% | $2.37M-53.4% | $5.08M+291% | -$2.66M-374% | ||
| $69K-95.3% | $1.47M— | $0-100% | $3.19M+349% | $711K-87.6% | ||
| -$5.78M-483% | $1.51M-34.9% | $2.32M+1,366% | $158K+13.7% | $139K-95.6% | ||
| $641K+385% | -$225K-123% | $965K— | $0-100% | $266K-25.3% | ||
| $498K+48.2% | $336K+240% | -$240K+79.2% | -$1.15M-38.6% | -$831K-4,255% | ||
| —— | —— | $0— | $0— | $0— | ||
| -$17.56M+29.2% | -$24.81M-110% | -$11.81M-744% | -$1.4M+89.2% | -$12.99M+39.4% | ||
| $7.89M-20.9% | $9.97M-19.7% | $12.43M+35.6% | $9.17M+121% | $4.14M+82.7% | ||
| $4.72M-77.0% | $20.51M-3.0% | $21.14M+674% | $2.73M-44.6% | $4.93M-76.1% | ||
| $5M-75.7% | $20.55M-2.9% | $21.16M— | $0-100% | $7.65M-64.1% | ||
| -$12.71M-27.9% | -$9.93M+19.9% | -$12.4M-32.0% | -$9.4M-559% | -$1.43M+7.2% | ||
| $0— | $0— | —— | —— | —— | ||
| $1.79M+496% | $300K-92.1% | $3.79M+107% | $1.83M+137% | $772K-73.8% | ||
| $4.14M+1,289% | $298K-94.7% | $5.57M+205% | $1.83M-42.9% | $3.2M-82.2% | ||
| —— | $9K-94.5% | $163K+330% | -$71K-168% | $104K+296% | ||
| -$26.13M+24.1% | -$34.44M-86.4% | -$18.48M-104% | -$9.04M+18.6% | -$11.11M-119% | ||
| $474K+158% | $184K-72.1% | $660K+9,329% | $7K-46.2% | $13K+333% | ||
| —— | —— | $0— | $0— | $0— | ||
| —— | -$12.44M— | —— | —— | —— | ||
| $11.13M+43.8% | $7.74M+308% | $1.9M-30.0% | $2.71M+339% | -$1.13M-555% | ||
| $498K+48.2% | $336K+240% | -$240K+79.2% | -$1.15M-38.6% | -$831K-4,255% | ||
| $5M-75.7% | $20.55M-2.9% | $21.16M— | $0-100% | $7.65M-64.1% | ||
| $8K+300% | $2K0.0% | $2K-33.3% | $3K-40.0% | $5K-16.7% | ||
| —— | —— | $1.78M— | —— | —— | ||
| $1.79M+496% | $300K-92.1% | $3.79M+107% | $1.83M+137% | $772K-73.8% | ||
| $4.36M+269% | $1.18M+102% | $586K+18.9% | $493K— | —— | ||
| $0— | $0— | —— | —— | —— | ||
| —— | $24.77M— | —— | —— | $0— | ||
| —— | —— | $0— | $0— | $0— | ||
| $474K+158% | $184K-72.1% | $660K+9,329% | $7K-46.2% | $13K+333% | ||
| -$25.45M+26.9% | -$34.79M-43.5% | -$24.24M-129% | -$10.57M+38.3% | -$17.13M+27.7% | ||
| -$25.45M+26.9% | -$34.79M-43.5% | -$24.24M-129% | -$10.57M+38.3% | -$17.13M+27.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Twist Bioscience Corporation generate?
- Twist Bioscience Corporation (TWST) generated -$55.6M in operating cash flow over the trailing twelve months.
- What is Twist Bioscience Corporation's free cash flow?
- After $39.5M of capital expenditures, Twist Bioscience Corporation's free cash flow was -$95.0M over the trailing twelve months, down 45.1% year over year.
- Where does Twist Bioscience Corporation's cash flow data come from?
- Every line is extracted from Twist Bioscience Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
